Investment Summary

1315 Capital Invests In Restorative Therapies

On December 25, 2018, growth capital firm 1315 Capital invested in medical products company Restorative Therapies

Investment Highlights
  • This is 1315 Capital’s 6th transaction in the Medical Products sector.
  • This is 1315 Capital’s 9th transaction in the United States.
  • This is 1315 Capital’s 1st transaction in Maryland.

Investment Summary
Date 2018-12-25
Target Restorative Therapies
Sector Medical Products
Investor(s) 1315 Capital
Deal Type Growth Capital

Target

Restorative Therapies

Baltimore, Maryland, United States
Restorative Therapies is a medical device company providing functional electrical stimulation to neurological rehabilitation patients. Restorative Therapies was founded in 2004 and is based in Baltimore, Maryland.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

1315 Capital

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2014
Size Small
Type Sector Focused
DESCRIPTION

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $40 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.

DEAL STATS #
Overall 10 of 21
Sector (Medical Products) 6 of 7
Type (Growth Capital) 2 of 6
State (Maryland) 1 of 1
Country (United States) 9 of 19
Year (2018) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-23 Genoptix

Carlsbad, California, United States

Genoptix, Inc. is one of the largest hematopathology testing laboratories in the U.S., providing thousands of oncologists and pathologists across the United States with comprehensive testing solutions in hematology and solid tumor molecular profiling. Genoptix, Inc. was founded in 1999 and is based in Carlsbad, California.

Sell $126M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-16 Biocoat

Horsham, Pennsylvania, United States

Biocoat develops and licenses biomaterial coatings for medical devices that are custom engineered to meet specific clinical parameters. The company specializes in supplying lubricious hydrophilic coatings for medical devices to original equipment manufacturers and contract manufacturers. Biocoat is able to recommend contract coaters or to provide in-house coating services to aspiring medical device companies that need help with manufacturing. The company also sells diagnostic test kits in the reproductive market for use in male factor infertility. Biocoat was founded in 1991 and is based in Horsham, Pennsylvania.

Buy -
Mergr

Product

Company

Legal